Aromasin and Joint injury - a phase IV clinical study of FDA data

Summary:

Joint injury is reported as a side effect among people who take Aromasin (exemestane), especially for people who are female, 60+ old, also take Femara, and have High blood pressure.

The phase IV clinical study analyzes which people have Joint injury when taking Aromasin. It is created by eHealthMe based on reports of 12,620 people who have side effects when taking Aromasin from the FDA, and is updated regularly.

What is Aromasin?

Aromasin has active ingredients of exemestane. It is often used in breast cancer. eHealthMe is studying from 12,863 Aromasin users. Check the latest studies of Aromasin.

What is Joint injury?

Joint injury is found to be associated with 1,237 drugs and 1,134 conditions by eHealthMe. Check the latest studies of Joint injury.

On Jul, 26, 2026

12,620 people reported to have side effects when taking Aromasin.
Among them, 36 people (0.29%) have Joint injury.

Among these 36 people:

What is the gender of people who have Joint injury when taking Aromasin? *

female: 97.06 %
male: 2.94 %

What is the age of people who have Joint injury when taking Aromasin? *

What are other drugs people take besides Aromasin? *

What are other side effects people have besides Joint injury? *

Fatigue (feeling of tiredness): 20 people, 55.56%
Joint Pain: 16 people, 44.44%
Pain: 14 people, 38.89%
Weakness: 13 people, 36.11%
Diarrhea: 13 people, 36.11%
Weight Decreased: 11 people, 30.56%
Rashes (redness): 11 people, 30.56%
Nausea And Vomiting: 11 people, 30.56%
Sinusitis (inflammation of sinus): 11 people, 30.56%
Bone Pain: 10 people, 27.78%

What are the existing conditions these people have? *

High Blood Pressure: 8 people, 22.22%
Breast Cancer Female: 7 people, 19.44%
High Blood Cholesterol: 6 people, 16.67%
Metastases To Bone (cancer spreads to bone): 6 people, 16.67%
Resorption Bone Increased: 5 people, 13.89%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 5 people, 13.89%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 5 people, 13.89%
Reflux Oesophagitis (an oesophageal mucosal injury that occurs of gastric contents into the oesophagus): 3 people, 8.33%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 8.33%
Nasal Congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels): 2 people, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Aromasin and have Joint injury?

- Check whether Joint injury is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Aromasin:

Aromasin (12,863 reports)

Joint injury treatments and more:

Joint injury (28,959 reports)

Browse all side effects of Aromasin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Joint injury:

Joint injury (1,237 drugs)

Browse all the conditions that are associated with Joint injury:

Joint injury (1,134 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on exemestane (the active ingredients of Aromasin) and Aromasin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.